EUVIMEDEUVIMED entdecken
Crossref

Kadar malondialdehida serum pada vitiligo awitan dini dan awitan lambat

Putu Nila Wardhani Batan, I Gusti Ayu Agung Praharsini, Anak Agung Gde Putra Wiraguna

Intisari Sains Medis · 28.03.2026 · 17 (1) · 239-245

DOI: 10.15562/ism.v17i1.2675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intisari Sains Medis, online erschienen am 28.03.2026. Verfasst von Putu Nila Wardhani Batan und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitiligo is a chronic depigmentation disorder in which oxidative stress plays a central pathogenic role. Malondialdehyde (MDA), the end product of lipid peroxidation, is consistently elevated in non-segmental vitiligo patients compared to healthy controls. However, a recent structured literature review has identified a complete absence of studies directly comparing MDA levels between early-onset and late-onset vitiligo, representing a significant knowledge gap.

Objective

To compare serum MDA levels and disease severity (VASI score) between early-onset (

Zitieren

APA

Batan, P. N. W., Praharsini, I. G. A. A., & Wiraguna, A. A. G. P. (2026). Kadar malondialdehida serum pada vitiligo awitan dini dan awitan lambat. Intisari Sains Medis, 17(1), 239-245. https://doi.org/10.15562/ism.v17i1.2675

Vancouver

Batan PNW, Praharsini IGAA, Wiraguna AAGP. Kadar malondialdehida serum pada vitiligo awitan dini dan awitan lambat. Intisari Sains Medis. 2026;17(1):239-245. doi:10.15562/ism.v17i1.2675

BibTeX
@article{Batan2026,
  author = {Batan, Putu Nila Wardhani and Praharsini, I Gusti Ayu Agung and Wiraguna, Anak Agung Gde Putra},
  title = {Kadar malondialdehida serum pada vitiligo awitan dini dan awitan lambat},
  journal = {Intisari Sains Medis},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {239--245},
  doi = {10.15562/ism.v17i1.2675}
}
Kostenlos starten →